U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
In 2017, an estimated 7.9% of persons aged 12 to 17 years reported illicit drug use in the past month, and an estimated 50% of adolescents in the US had used an illicit drug by the time they graduated from high school. Young adults aged 18 to 25 years have a higher rate of current illicit drug use, with an estimated 23.2% currently using illicit drugs. Illicit drug use is associated with many negative health, social, and economic consequences and is a significant contributor to 3 of the leading ...
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
It is not recommended a screening for bacterial vaginosis in pregnant women without an increased risk of preterm delivery. In pregnant women who are at increased risk of preterm birth, the USPSTF concludes that current evidence is insufficient to assess the balance of benefits and harms of bacterial vaginosis screening.
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance.
U.S. Preventive Services Task Force A and B recommendations
U.S. Preventive Services Task Force
The USPSTF found that the evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults. More research is needed. Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person’s independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individuals in the United States, and its prevalence increases with age.
In this Cochrane rapid review, the authors searched for studies of the diagnostic accuracy of routine laboratory testing as a triage test for COVID-19. At the time of this review, the included studies showed that none of the 67 different laboratory tests reviewed could be used to accurately rule in or rule out COVID-19 on their own, due to low sensitivity and specificity.
At the time of this review, the included studies showed that only three tests had a summary sensitivity and specificity ...